Dr Eyad Elkord has different positions as Associate Professor of Immunology at College of Medicine & Health Sciences-United Arab Emirates University, UAE; an Honorary Professor at the Institute of Cancer Sciences-University of Manchester, UK; and an Honorary Senior Lecturer at the School of Environment & Life Sciences-University of Salford, UK. He received his BSc in 1995 from Al-Quds University (Jerusalem, Palestine), M.Phil in 2001 from Bergen University (Norway) and PhD in Tumour Immunology in 2005 from University of Wales College of Medicine, Cardiff University (UK). He was a Postdoctoral Scientist (Jan 2005-Dec 2007) in the laboratory of Prof. Peter Stern at the Paterson Institute for Cancer Research, University of Manchester (UK). He then was promoted to a Research Fellow/Group Leader of the Clinical Immunotherapy Laboratory at the University of Manchester (Jan 2008-Nov 2010). He then undertook a faculty position as Lecturer with the School of Environment & Life Sciences, University of Salford (Dec 2010-July 2012), and was then promoted from August 2012 to a Senior Lecturer position. Dr Elkord is a member of scientific societies, including, British Society for Immunology, European Academy of Allergology and Clinical Immunology, Immunology Interest Group (National Institutes of Health) and European Macrophage and Dendritic Cell Society. He is a recipient of the Deans annual research prize, College of Science & Technology, University of Salford, UK for 2012 and an award of a certificate of achievement for publishing in top journals and bringing recognition to UAE University in May 2015. Dr Elkord is an editorial board member for peer-reviewed international journals such as BMC Cancer and Journal of Immunology Research. He is ad hoc reviewer to many international journals and well-known grant bodies including Medical Research Council, Wellcome Trust, Yorkshire Cancer Research, Leukaemia Lymphoma Research and Qatar Foundation. Dr Elkord’s research in the area of T regulatory cells is well recognized and as a result he has edited an eBook for Frontiers in Immunology in 2013. He is a contributing author to The Halifax Project task force focused on A Broad- Spectrum Integrative Design for Cancer Prevention and Therapy. He has presented his work in different national and international meetings and conferences. Dr Elkord has more than 45 publications in peer reviewed high-impact international journals (most of them as first or senior author) with more than 1220 citations and an h-index of 19 and M-index of 2.1.